
technologyAug 26, 202535:44pending
n8n CEO Jan Oberhauser on Building the Universal AI Automation Layer
About this episode
When the AI wave hit, n8n founder Jan Oberhauser faced a critical choice: become irrelevant or become indispensable. He chose the latter, transforming n8n from a simple workflow tool into a comprehensive AI automation platform that lets users connect any LLM to any application. The result? Four times the revenue growth in eight months compared to the previous six years. Jan explains how n8n’s “connect everything to anything” philosophy, combined with a thriving open source community, positioned the company to ride the AI automation wave while avoiding vendor lock-in that plagues enterprise software.
Hosted by George Robson and Pat Grady, Sequoia Capital
Mentioned in this episode:
Model Context Protocol (MCP): Open protocol that lets AI models safely use external tools and data that is used extensively by n8n for orchestration.
Vector database: A database optimized for storing and searching embeddings. These “vector stores” can pair with LLMs for retrieval-augmented workflows.
Granola: AI productivity tool mentioned by Jan as a recent favorite.
Her: A film that Jan says, “a few years ago, it was sci fi, and it’s now suddenly this thing that is just around the corner.”
Get every episode summarized
Each time Training Data publishes, we email you a written briefing from the transcript — the topics, who appeared, and any specific claims, with the ad reads skipped.
Email me new episodesFree for 3 shows. No card needed.
Hosts & guests
No transcript yet
This episode has not been transcribed. Request it and it moves to the front of the queue.
More episodes
More from Training Data

Making Cities Awesome: Peregrine’s Nick Noone & Ben Rudolph
Training Data
Sep 1, 202652:27pending

Parallel’s Parag Agrawal: Building a New Web for AI Agents
Training Data
Aug 25, 202655:18pending

Rich Sutton and Khurram Javed: Why AI Models Stop Learning, and How to Start It...
Training Data
Aug 18, 202653:43pending

Chai Discovery's Bitter Lesson: Drug Design Is Another Scaling Problem
Training Data
Aug 4, 202647:22pending